In the latest quarter, 16 analysts provided ratings for NOV NOV, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 4 | 3 | 4 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 4 | 2 | 0 | 3 | 0 |
| 3M Ago | 1 | 2 | 1 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $20.06, a high estimate of $25.00, and a low estimate of $15.00. Experiencing a 9.84% decline, the current average is now lower than the previous average price target of $22.25.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive NOV is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Waqar Syed | ATB Capital | Maintains | Sector Perform | $19.00 | $19.00 |
| Scott Gruber | Citigroup | Lowers | Neutral | $18.00 | $21.00 |
| Roger Read | Wells Fargo | Lowers | Underweight | $15.00 | $16.00 |
| David Anderson | Barclays | Lowers | Underweight | $16.00 | $17.00 |
| Marc Bianchi | TD Cowen | Lowers | Buy | $22.00 | $28.00 |
| Charles Minervino | Susquehanna | Lowers | Positive | $21.00 | $22.00 |
| Stephen Gengaro | Stifel | Lowers | Buy | $24.00 | $25.00 |
| David Anderson | Barclays | Lowers | Underweight | $17.00 | $20.00 |
| Saurabh Pant | B of A Securities | Lowers | Buy | $20.00 | $22.00 |
| Stephen Gengaro | Stifel | Lowers | Buy | $25.00 | $26.00 |
| Charles Minervino | Susquehanna | Lowers | Positive | $22.00 | $26.00 |
| Phillip Jungwirth | BMO Capital | Lowers | Market Perform | $20.00 | $22.00 |
| Scott Gruber | Citigroup | Lowers | Buy | $21.00 | $24.00 |
| Arun Jayaram | JP Morgan | Lowers | Overweight | $22.00 | $23.00 |
| Roger Read | Wells Fargo | Lowers | Underweight | $16.00 | $20.00 |
| Elizabeth Porter | Morgan Stanley | Lowers | Overweight | $23.00 | $25.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to NOV. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of NOV compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for NOV's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into NOV's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on NOV analyst ratings.
About NOV
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
NOV: Financial Performance Dissected
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: NOV displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 0.27%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: NOV's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.93% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): NOV's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.02%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.14%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.37.
Understanding the Relevance of Analyst Ratings
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
